Related Experiment Video
Updated: Jan 28, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
Case 344: Hepatic Epithelioid Hemangioendothelioma
Lasya Daggumati1, Lauren Stark2, Adam L Booth2
1University of Missouri Kansas City School of Medicine, Kansas City, Mo.
History:
A previously healthy 33-year-old woman presented with several months of intermittent right upper quadrant discomfort, early satiety, bloating, and nausea. She had no remarkable past medical or surgical history, specifically no known malignancy, chronic liver disease, or substance abuse. She had four biologic children and reported no current or prior oral contraceptive use. Physical examination revealed normal vital signs and a soft, nontender abdomen. Laboratory studies included a hepatic function panel, which was normal. Results for serum tumor marker tests included an α-fetoprotein level of 2.1 μg/L (reference range, ≤8.3 μg/L), a carcinoembryonic antigen level less than 0.6 μg/L (reference range, ≤5.0 μg/L), and a cancer antigen 19-9 level of 17.4 kU/L (reference range, ≤35.0 kU/L). A urine pregnancy test was negative. CT of the abdomen and pelvis with intravenous contrast material was performed. No extrahepatic pathologic features were identified. MRI of the abdomen without and with intravenous contrast material was performed, for further evaluation of the liver findings.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

